Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 23 matching records.
23 results — page 1 of 1
- Level DNarrative ReviewEurope PMC
Recommendations for the safe implementation of intravenous administration of mesenchymal stromal cells
Narrative Review on Systemic / IV, published in Regen Ther (2025) — summary generated from the PubMed abstract.
- 2025
Regen Ther4 citations - Level CProspective StudyPubMed
Intravenous Administration of Human-Derived Mesenchymal Stem Cell-Conditioned Medium for Patients with General Malaise.
Prospective Study with a reported sample of 19 on Chronic Inflammation, published in J Clin Med (2025) — summary generated from the PubMed abstract.
- 2025
- n = 19
J Clin Med - Level DLaboratory StudyPubMed
Tracking of autologous adipose-derived mesenchymal stromal/stem cells after intravenous administration: a pilot study in a dog with induced acute bladder injury.
Laboratory Study on Scar, published in Front Vet Sci (2025) — summary generated from the PubMed abstract.
- 2025
Front Vet Sci - Level CRetrospective StudyPubMed
Systematic Intravenous Administration of Autologous Mesenchymal Stem Cells Is Safe.
Retrospective Study with a reported sample of 2504 on Cardiovascular Disease, published in J Clin Med (2024) — summary generated from the PubMed abstract.
- 2024
- n = 2504
J Clin Med2 citations - Level DLaboratory StudyPubMed
Intravenous Administration of Human Umbilical Cord Mesenchymal Stromal Cells Leads to an Inflammatory Response in the Lung.
Laboratory Study on Chronic Inflammation, Immune Modulation, published in Stem Cells Int (2023) — summary generated from the PubMed abstract.
- 2023
Stem Cells Int - Level DAnimal StudyPubMed
Intravenous administration of mesenchymal stromal cells leads to a dose-dependent coagulopathy and is unable to attenuate acute traumatic coagulopathy in rats.
Animal Study on Face & Skin, Systemic / IV, published in J Trauma Acute Care Surg (2022) — summary generated from the PubMed abstract.
- 2022
J Trauma Acute Care Surg - Level DAnimal StudyPubMed
Intravenous administration of human mesenchymal stem cells derived from adipose tissue and umbilical cord improves neuropathic pain via suppression of neuronal damage and anti-inflammatory actions in rats.
Animal Study on Chronic Inflammation, Immune Modulation, published in PLoS One (2022) — summary generated from the PubMed abstract.
- 2022
PLoS One25 citations - Level BClinical TrialEurope PMC
Topical and intravenous administration of human umbilical cord mesenchymal stem cells in patients with diabetic foot ulcer and peripheral arterial disease: a phase I pilot study with a 3-year follow-up
Clinical Trial with a reported sample of 14 on Diabetic Foot, Peripheral Artery Disease, published in Stem Cell Res Ther (2022) — summary generated from the PubMed abstract.
- 2022
- n = 14
Stem Cell Res Ther54 citations - Level CCase Report / SeriesPubMed
Frequency-dependent effect of intravenous administration of human adipose-derived mesenchymal stem cell therapy for severe Systemic Lupus Erythematosus: A case report.
Case Report / Series on Immune Modulation, Autoimmune Research, published in J Transl Autoimmun (2022) — summary generated from the PubMed abstract.
- 2022
J Transl Autoimmun1 citations - Level DAnimal StudyPubMed
Optimal Intravenous Administration Procedure for Efficient Delivery of Canine Adipose-Derived Mesenchymal Stem Cells.
Animal Study on Systemic / IV, published in Int J Mol Sci (2022) — summary generated from the PubMed abstract.
- 2022
Int J Mol Sci4 citations - Level DNarrative ReviewEurope PMC
Therapeutic Potential of Mesenchymal Stem Cells and Their Products in Lung Diseases-Intravenous Administration versus Inhalation
Narrative Review on Systemic / IV, published in Pharmaceutics (2021) — summary generated from the PubMed abstract.
- 2021
Pharmaceutics27 citations - Level CCase Report / SeriesPubMed
Hypothesis: Intravenous administration of mesenchymal stem cells is effective in the treatment of Alzheimer's disease.
Case Report / Series on Neuroinflammation, Chronic Inflammation, published in Med Hypotheses (2021) — summary generated from the PubMed abstract.
- 2021
Med Hypotheses10 citations - Level DAnimal StudyPubMed
The intravenous administration of skin-derived mesenchymal stem cells ameliorates hearing loss and preserves cochlear hair cells in cisplatin-injected mice: SMSCs ameliorate hearing loss and preserve outer hair cells in
Animal Study on Chronic Inflammation, published in Hear Res (2021) — summary generated from the PubMed abstract.
- 2021
Hear Res - Level DAnimal StudyEurope PMC
Intravenous Administration of Human Amniotic Mesenchymal Stem Cells in the Subacute Phase of Cerebral Infarction in a Mouse Model Ameliorates Neurological Disturbance by Suppressing Blood Brain Barrier Disruption and Apo
Animal Study on Stroke Research, Scar, Immune Modulation, published in Cell Transplant (2021) — summary generated from the PubMed abstract.
- 2021
Cell Transplant22 citations - Level CProspective StudyPubMed
Intravenous Administration of Human Adipose Derived-Mesenchymal Stem Cells Is Not Efficient in Diabetic or Hypertensive Mice Subjected to Focal Cerebral Ischemia.
Prospective Study on Stroke Research, Immune Modulation, published in Front Neurosci (2019) — summary generated from the PubMed abstract.
- 2019
Front Neurosci11 citations - Level DAnimal StudyPubMed
Intravenous administration of anti-inflammatory mesenchymal stem cell spheroids reduces chronic alcohol intake and abolishes binge-drinking.
Animal Study on Neuroinflammation, Chronic Inflammation, published in Sci Rep (2018) — summary generated from the PubMed abstract.
- 2018
Sci Rep37 citations - Level DAnimal StudyEurope PMC
Dose-Dependent Effect of Intravenous Administration of Human Umbilical Cord-Derived Mesenchymal Stem Cells in Neonatal Stroke Mice
Animal Study on Stroke Research, published in Front Neurol (2018) — summary generated from the PubMed abstract.
- 2018
Front Neurol54 citations - Level DAnimal StudyPubMed
Intravenous Administration of Bone Marrow-Derived Mesenchymal Stem Cell, but not Adipose Tissue-Derived Stem Cell, Ameliorated the Neonatal Hypoxic-Ischemic Brain Injury by Changing Cerebral Inflammatory State in Rat.
Animal Study on Chronic Inflammation, published in Front Neurol (2018) — summary generated from the PubMed abstract.
- 2018
Front Neurol42 citations - Level BRandomized Controlled TrialPubMed
Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled
Randomized Controlled Trial with a reported sample of 6 on Tendon Injury, Autoimmune Research, published in Ann Rheum Dis (2016) — summary generated from the PubMed abstract.
- 2016
- n = 6
Ann Rheum Dis205 citations - Level DAnimal StudyPubMed
Intravenous administration of xenogenic adipose-derived mesenchymal stem cells (ADMSC) and ADMSC-derived exosomes markedly reduced brain infarct volume and preserved neurological function in rat after acute ischemic stro
Animal Study with a reported sample of 60 on Stroke Research, published in Oncotarget (2016) — summary generated from the PubMed abstract.
- 2016
- n = 60
Oncotarget190 citations - Level DAnimal StudyPubMed
Intravenous vs intraperitoneal mesenchymal stem cells administration: what is the best route for treating experimental colitis?
Animal Study on Chronic Inflammation, Immune Modulation, published in World J Gastroenterol (2014) — summary generated from the PubMed abstract.
- 2014
World J Gastroenterol - Level DAnimal StudyPubMed
Effects of intravenous administration of allogenic bone marrow- and adipose tissue-derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic stroke.
Animal Study on Stroke Research, published in Stem Cell Res Ther (2013) — summary generated from the PubMed abstract.
- 2013
Stem Cell Res Ther171 citations - Level DAnimal StudyPubMed
Comparison of in vivo immunomodulatory effects of intravenous and intraperitoneal administration of adipose-tissue mesenchymal stem cells in experimental autoimmune encephalomyelitis (EAE).
Animal Study on Neuroinflammation, Chronic Inflammation, Immune Modulation, Autoimmune Research, published in Int Immunopharmacol (2013) — summary generated from the PubMed abstract.
- 2013
Int Immunopharmacol
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406